Brief: Hyperfine Secures FDA Approval for Optive AI on Swoop® System
Dec 15 (Reuters) - Hyperfine Inc HYPR.O: HYPERFINE ANNOUNCES FDA CLEARANCE OF THE FIRST OPTIVE AI™ SOFTWARE UPDATE WITH ADVANCED DIFFUSION IMAGING CAPABILITY, FOCUSED ON ENHANCING STROKE DETECTION WITH THE SWOOP® SYSTEM Source text: ID:nBw9kvncDa Further company coverage: HYPR.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hyperfine
See all newsPortable MRI maker Hyperfine's Q3 prelim revenue beats estimates; FY outlook reaffirmed
Brief: Hyperfine, Inc. Q3 Sales USD 6 Million
Hyperfine Inc reports results for the quarter ended June 30 - Earnings Summary
Portable MRI maker Hyperfine's Q2 revenue rises less than expected
Brief: Hyperfine, Inc. Q2 EPS USD -0.09